Roche announces trial successes in cancer, haemophilia
ZURICH (Reuters) - Roche announced a double dose of trial wins on Monday, saying its immunotherapy Tecentriq mixed with other drugs made advances against lung cancer, while data suggested its haemophilia agent Hemlibra could be used by more patients.
from Reuters: Health News http://ift.tt/2zS3qyM
http://ift.tt/xePdMM